Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice

被引:157
作者
Zykova, SN [1 ]
Jenssen, TG
Berdal, M
Olsen, R
Myklebust, R
Seljelid, R
机构
[1] Univ Tromso, Inst Med Biol, N-9037 Tromso, Norway
[2] Univ Tromso, Inst Clin Med, N-9037 Tromso, Norway
关键词
D O I
10.2337/diabetes.49.9.1451
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Macrophage dysfunction is a likely mechanism underlying common diabetic complications such as increased susceptibility to infection, accelerated atherosclerosis, and disturbed wound healing. There are no available studies on the function of tissue macrophages in diabetes in humans. We have therefore studied peritoneal macrophages from diabetic type 2-like db/db mice. We found that the release of tumor necrosis factor-alpha and interleukin-1 beta from lipopolysaccharide plus interferon-gamma-stimulated macrophages and vascular endothelial. growth factor from both stimulated and nonstimulated macrophages was significantly reduced in diabetic animals compared with nondiabetic controls. Nitric oxide production from the stimulated db/db macrophages was significantly higher than that in the db/+ cultures, whereas there was no difference in their ability to generate reactive oxygen species. When studied both at light and electron microscopic levels, macrophages in diabetic animals had an altered morphological appearance compared with those of normal controls. We conclude that the function and morphology of the macrophages are disturbed in db/db mice and that this disturbance is related to the mechanisms underlying common inflammatory and degenerative manifestations in diabetes.
引用
收藏
页码:1451 / 1458
页数:8
相关论文
共 49 条
[21]   DEFECTIVE MATURATION AND FUNCTION OF ANTIGEN-PRESENTING CELLS IN TYPE-1 DIABETES [J].
JANSEN, A ;
VANHAGEN, M ;
DREXHAGE, HA .
LANCET, 1995, 345 (8948) :491-492
[22]  
JOSEFSEN K, 1994, CLIN EXP IMMUNOL, V98, P489
[23]   The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1 [J].
Jude, EB ;
Boulton, AJM ;
Ferguson, MWJ ;
Appleton, I .
DIABETOLOGIA, 1999, 42 (06) :748-757
[24]   PHAGOCYTOTIC ACTIVITY OF MONOCYTES FROM DIABETIC-PATIENTS [J].
KATZ, S ;
KLEIN, B ;
ELIAN, I ;
FISHMAN, P ;
DJALDETTI, M .
DIABETES CARE, 1983, 6 (05) :479-482
[25]   TNF production from peripheral blood mononuclear cells in diabetic patients after stimulation with alginate and lipopolysaccharide [J].
Kulseng, B ;
SkjakBraek, G ;
Folling, I ;
Espevik, T .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 43 (03) :335-340
[26]   TUMOR-NECROSIS-FACTOR PRODUCTION IS DEFICIENT IN DIABETES-PRONE BB RATS AND CAN BE CORRECTED BY COMPLETE FREUND ADJUVANT - A POSSIBLE IMMUNOREGULATORY ROLE OF TUMOR-NECROSIS-FACTOR IN THE PREVENTION OF DIABETES [J].
LAPCHAK, PH ;
GUILBERT, LJ ;
RABINOVITCH, A .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 65 (02) :129-134
[27]   Abnormal splicing of the leptin receptor in diabetic mice [J].
Lee, GH ;
Proenca, R ;
Montez, JM ;
Carroll, KM ;
Darvishzadeh, JG ;
Lee, JI ;
Friedman, JM .
NATURE, 1996, 379 (6566) :632-635
[28]  
LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71
[29]  
Ling X, 1998, LAB INVEST, V78, P1591
[30]   Leptin regulates proinflammatory immune responses [J].
Loffreda, S ;
Yang, SQ ;
Lin, HZ ;
Karp, CL ;
Brengman, ML ;
Wang, DJ ;
Klein, AS ;
Bulkley, GB ;
Bao, C ;
Noble, PW ;
Lane, MD ;
Diehl, AM .
FASEB JOURNAL, 1998, 12 (01) :57-65